# East West Bancorp Inc: financial statements, quarterly

EWBC · Nasdaq · CIK 1069157 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ewbc.md) · [Financials](/companies/ewbc/financials.md) · [Filings](/companies/ewbc/filings.md) · [Insiders](/companies/ewbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ewbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [391](/filings/0001069157-23-000114.md) | [416 d](/filings/0001069157-24-000020.md) | [458](/filings/0001069157-24-000046.md) | [481](/filings/0001069157-24-000090.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [65.8](/filings/0001069157-24-000111.md) | [88.3 d](/filings/0001069157-26-000009.md) | [87.2](/filings/0001069157-25-000052.md) | [76.2](/filings/0001069157-25-000096.md) | [90.2](/filings/0001069157-25-000119.md) | [62.7 d](/filings/0001069157-26-000009.md) | [101](/filings/0001069157-26-000020.md) | [92.0](/filings/0001069157-26-000044.md) | [96.7](/filings/0001069157-25-000119.md) | [111 d](/filings/0001069157-26-000009.md) | [99.6](/filings/0001069157-26-000020.md) | [104](/filings/0001069157-26-000044.md) |
| Net income | $m | [288](/filings/0001069157-24-000111.md) | [239 d](/filings/0001069157-26-000009.md) | [285](/filings/0001069157-25-000052.md) | [288](/filings/0001069157-25-000096.md) | [299](/filings/0001069157-25-000119.md) | [293 d](/filings/0001069157-26-000009.md) | [290](/filings/0001069157-26-000020.md) | [310](/filings/0001069157-26-000044.md) | [368](/filings/0001069157-25-000119.md) | [356 d](/filings/0001069157-26-000009.md) | [358](/filings/0001069157-26-000020.md) | [364](/filings/0001069157-26-000044.md) |
| Diluted EPS | $ per share | [2.02](/filings/0001069157-24-000111.md) | not reported | [2.03](/filings/0001069157-25-000052.md) | [2.06](/filings/0001069157-25-000096.md) | [2.14](/filings/0001069157-25-000119.md) | not reported | [2.08](/filings/0001069157-26-000020.md) | [2.24](/filings/0001069157-26-000044.md) | [2.65](/filings/0001069157-25-000119.md) | not reported | [2.57](/filings/0001069157-26-000020.md) | [2.63](/filings/0001069157-26-000044.md) |
| Basic EPS | $ per share | [2.03](/filings/0001069157-24-000111.md) | not reported | [2.04](/filings/0001069157-25-000052.md) | [2.07](/filings/0001069157-25-000096.md) | [2.16](/filings/0001069157-25-000119.md) | not reported | [2.10](/filings/0001069157-26-000020.md) | [2.25](/filings/0001069157-26-000044.md) | [2.68](/filings/0001069157-25-000119.md) | not reported | [2.59](/filings/0001069157-26-000020.md) | [2.65](/filings/0001069157-26-000044.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.6](/filings/0001069157-23-000114.md) | [4.6](/filings/0001069157-25-000025.md) | [4.2](/filings/0001069157-24-000046.md) | [4.4](/filings/0001069157-24-000090.md) | [4.9](/filings/0001069157-24-000111.md) | [5.3](/filings/0001069157-26-000009.md) | [3.4](/filings/0001069157-25-000052.md) | [4.4](/filings/0001069157-25-000096.md) | [4.7](/filings/0001069157-25-000119.md) | [4.2](/filings/0001069157-26-000044.md) | [4.4](/filings/0001069157-26-000020.md) | [5.1](/filings/0001069157-26-000044.md) |
| Total assets | $bn | [68.3](/filings/0001069157-24-000111.md) | [69.6](/filings/0001069157-26-000009.md) | [70.9](/filings/0001069157-25-000052.md) | [72.5](/filings/0001069157-25-000096.md) | [74.5](/filings/0001069157-25-000119.md) | [76.0](/filings/0001069157-26-000009.md) | [76.2](/filings/0001069157-26-000020.md) | [78.2](/filings/0001069157-26-000044.md) | [79.7](/filings/0001069157-25-000119.md) | [80.4](/filings/0001069157-26-000044.md) | [82.9](/filings/0001069157-26-000020.md) | [84.8](/filings/0001069157-26-000044.md) |
| Total liabilities | $bn | [61.7](/filings/0001069157-23-000114.md) | [62.7](/filings/0001069157-25-000025.md) | [63.9](/filings/0001069157-24-000046.md) | [65.3](/filings/0001069157-24-000090.md) | [66.8](/filings/0001069157-24-000111.md) | [68.3](/filings/0001069157-26-000009.md) | [68.2](/filings/0001069157-25-000052.md) | [70.0](/filings/0001069157-25-000096.md) | [71.1](/filings/0001069157-25-000119.md) | [71.5](/filings/0001069157-26-000044.md) | [73.9](/filings/0001069157-26-000020.md) | [75.5](/filings/0001069157-26-000044.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.6](/filings/0001069157-24-000111.md) | [7.0](/filings/0001069157-26-000009.md) | [7.0](/filings/0001069157-25-000096.md) | [7.2](/filings/0001069157-25-000119.md) | [7.7](/filings/0001069157-25-000119.md) | [7.7](/filings/0001069157-26-000044.md) | [7.9](/filings/0001069157-26-000044.md) | [8.2](/filings/0001069157-26-000044.md) | [8.6](/filings/0001069157-25-000119.md) | [8.9](/filings/0001069157-26-000044.md) | [9.0](/filings/0001069157-26-000044.md) | [9.2](/filings/0001069157-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [383 d](/filings/0001069157-24-000111.md) | [562 d](/filings/0001069157-26-000009.md) | [266](/filings/0001069157-25-000052.md) | [259 d](/filings/0001069157-25-000096.md) | [386 d](/filings/0001069157-25-000119.md) | [500 d](/filings/0001069157-26-000009.md) | [278](/filings/0001069157-26-000020.md) | [279 d](/filings/0001069157-26-000044.md) | [232 d](/filings/0001069157-25-000119.md) | [713 d](/filings/0001069157-26-000009.md) | [429](/filings/0001069157-26-000020.md) | [601 d](/filings/0001069157-26-000044.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | [2.5](/filings/0001069157-26-000020.md) | [2.1 d](/filings/0001069157-26-000044.md) | not reported | not reported | [99.0](/filings/0001069157-26-000020.md) | [13.5 d](/filings/0001069157-26-000044.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001069157-24-000111.md) | [82.2 d](/filings/0001069157-26-000009.md) | [82.4](/filings/0001069157-25-000052.md) | [40.8 d](/filings/0001069157-25-000096.md) | [0.0 d](/filings/0001069157-25-000119.md) | [19.9 d](/filings/0001069157-26-000009.md) | [85.4](/filings/0001069157-26-000020.md) | [3.7 d](/filings/0001069157-26-000044.md) | [25.4 d](/filings/0001069157-25-000119.md) | [1.0 d](/filings/0001069157-26-000009.md) | [97.8](/filings/0001069157-26-000020.md) | [(0.0) d](/filings/0001069157-26-000044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [142](/filings/0001069157-23-000114.md) | [142](/filings/0001069157-24-000046.md) | [142](/filings/0001069157-24-000090.md) | [142](/filings/0001069157-24-000111.md) | [140](/filings/0001069157-25-000052.md) | [140](/filings/0001069157-25-000096.md) | [140](/filings/0001069157-25-000119.md) | [139](/filings/0001069157-26-000020.md) | [139](/filings/0001069157-26-000044.md) | [139](/filings/0001069157-25-000119.md) | [139](/filings/0001069157-26-000020.md) | [138](/filings/0001069157-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 137,011,856 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001069157-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.